Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Spasmodic dysphonia is a neurological voice disorder characterized by involuntary adductor (towards midline) or abductor (away from midline) vocal fold spasms during phonation which result in phonatory breaks. Botulinum toxin is currently the gold standard of treatment. Objective: To determine the efficacy of botulinum toxin therapy for the treatment of spasmodic dysphonia. Design: Systematic Cochrane review. Search strategy: The search strategy for this review complied with Cochrane standards. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 to February 2005), EMBASE (1974 to February 2005), CINAHL (through February 2005), Dissertation Abstracts International (1975 to February 2005) and PsycINFO (1975 to February 2005). The search engine FirstSearch was also used (February 2005). Reference lists for all the obtained studies and other review articles were examined for additional studies. Selection criteria: All randomized control trials where the participants were randomly allocated prior to intervention and in which botulinum toxin was compared to an alternative treatment, placebo or non-treated control group were included. Data collection and analysis: Two reviewers independently evaluated all potential studies meeting the selection criteria noted above for inclusion. Main results: Only one study in the literature met the inclusion criteria. This was the only study identified which reported a treatment/no treatment comparison. It reported significant beneficial effects for fundamental frequency (Fo), Fo range, spectrographic analysis, independent ratings of voice severity and patient ratings of voice improvement. Reviewer's conclusions: The evidence from randomized controlled trials supporting the effectiveness of botulinum toxin for management of spasmodic dysphonia is deficient. The lack of supporting evidence from randomized controlled trials results in an inability to draw unbiased generalized conclusions regarding the effectiveness of botulinum toxin for all types of spasmodic dysphonia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blitzer, A., Brin, M. F., & Stewart, C. F. (1998) · The Laryngoscope · doi:10.1097/00005537-199810000-00003 · Cited by 391
Cited by
Dysarthria in amyotrophic lateral sclerosis: A review
Tomik, B., & Guiloff, R. J. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802379004 · Cited by 201
The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients
Patel, A. B., Bansberg, S. F., Adler, C. H., Lott, D. G., & Crujido, L. (2015) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/0003489415588557 · Cited by 60
“The use of BoNT-A has remained the gold standard and allows for short-duration and symptom-based management.(1,6,21-22) As we continue to make advances in the evaluation and treatment of spasmodic dysphonia, we must revisit key variables surrounding the demographics surrounding spasmodic dysphonia.”
BackgroundDejonckere, P. H., Neumann, K. J., Moerman, M. B. J., Martens, J. P., Giordano, A., & Manfredi, C. (2012) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-011-1890-6 · Cited by 30
“However, treatment with Botulinum injection is universally considered as the ‘gold standard’ symptomatic treatment for adductor SD [1, 12].”
Metadata
- Authors
- Watts, C., Nye, C., & Whurr, R.
- Venue
- Clinical Rehabilitation
- Publisher
- SAGE Publications
- Published
- 2006-02
- Volume
- 20
- Issue
- 2
- Pages
- 112-122
- ISSN
- 0269-2155 (ISSN-L)
- 1477-0873
- OpenAlex
- W2159217036
- Cited by
- 78
- References
- 1
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. https://app.cochat.ai/papers/10.1191/0269215506cr931oa
- The paper
- Watts, C., Nye, C., & Whurr, R. (2006). Botulinum toxin for treating spasmodic dysphonia (laryngeal dystonia): a systematic Cochrane review. Clinical Rehabilitation. https://doi.org/10.1191/0269215506cr931oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.